Literature DB >> 22616627

Prostate cancer incidence and mortality in rural men--a systematic review of the literature.

Z Obertova1, C Brown, M Holmes, R Lawrenson.   

Abstract

INTRODUCTION: Prostate cancer is a common health problem in men worldwide. This systematic review has been undertaken to determine if there are differences in incidence of and mortality from prostate cancer between rural and urban men. The understanding of geographical patterns of prostate cancer incidence and mortality is necessary in order to identify and assess any disparities between rural and urban residents in gaining access to healthcare services, such as screening, diagnosis and treatment.
METHODS: Medline, CINAHL and Embase were searched using relevant mesh phrases, such as 'prostate cancer incidence rural' or 'prostatic neoplasms mortality rural'. Secondary literature and reports not published in peer-reviewed journals were included if inclusion criteria had been met. The following inclusion criteria were applied: cohort (population-based study) of adult men, diagnosis of prostate cancer, comparing rural and urban groups, and incidence or mortality with available statistical parameters as outcome.
RESULTS: In total, 25 studies were found to fit the inclusion criteria. Sixteen cohort studies were identified that examined incidence of prostate cancer in rural and urban populations, while 18 studies focused on mortality. Nine of these publications discussed both aspects. Twenty of these studies were published in scientific journals, while five were reports identified through secondary literature search. Prostate cancer incidence was found to be higher in urban men, while mortality patterns seemed to vary to some degree depending on different definitions of rural/urban groups, as well as on variations in demographic factors and study periods. There is evidence, however, that after prostate-specific antigen testing was introduced death rates tended to be higher in rural men with prostate cancer.
CONCLUSIONS: The review of the literature showed that in spite of inconsistent definitions of rural/urban categories among studies the majority reported higher incidence rates in urban men. This finding suggests that rural men are less likely to be screened and less likely to be subsequently diagnosed with prostate cancer. Although mortality patterns tended to be heterogeneous, there was some evidence that rural residents with prostate cancer experience higher death rates. It would be beneficial if future studies take into consideration factors such as stage at initial diagnosis, ethnicity, and socioeconomic and health status when assessing differences in cancer outcomes. Few studies in this review accounted for one or more of these variables, although there are indications that they contribute to differences in prostate cancer incidence and mortality between rural and urban populations.

Entities:  

Mesh:

Year:  2012        PMID: 22616627

Source DB:  PubMed          Journal:  Rural Remote Health        ISSN: 1445-6354            Impact factor:   1.759


  16 in total

1.  Rural-urban differences in acute myocardial infarction mortality: Evidence from Nebraska.

Authors:  Soumitra Sudip Bhuyan; Yang Wang; Samuel Opoku; Ge Lin
Journal:  J Cardiovasc Dis Res       Date:  2014-02-22

2.  Family physician access to and wait times for cancer diagnostic investigations: Regional differences among 3 provinces.

Authors:  Andriana Barisic; Maxine Kish; Julie Gilbert; Nicole Mittmann; Rahim Moineddin; Jeffrey Sisler; Peter Vedsted; Eva Grunfeld
Journal:  Can Fam Physician       Date:  2016-10       Impact factor: 3.275

3.  Associations of Prostate-Specific Antigen (PSA) Testing in the US Population: Results from a National Cross-Sectional Survey.

Authors:  Jarrett A Johnson; Richard P Moser; Gary L Ellison; Damali N Martin
Journal:  J Community Health       Date:  2020-10-16

Review 4.  Prostate adenocarcinoma associated with prostatic infection due to Schistosoma haematobium. Case report and systematic review.

Authors:  Jacinta Chaves Figueiredo; Joachim Richter; Nilo Borja; Antonino Balaca; Sandra Costa; Silvana Belo; Maria Amélia Grácio
Journal:  Parasitol Res       Date:  2014-12-30       Impact factor: 2.289

5.  Building Capacity in a Rural North Carolina Community to Address Prostate Health Using a Lay Health Advisor Model.

Authors:  Anissa I Vines; Jaimie C Hunter; Brandolyn S White; Alan N Richmond
Journal:  Health Promot Pract       Date:  2015-07-31

6.  Risk of several cancers is higher in urban areas after adjusting for socioeconomic status. Results from a two-country population-based study of 18 common cancers.

Authors:  Linda Sharp; David Donnelly; Avril Hegarty; Anne-Elie Carsin; Sandra Deady; Neil McCluskey; Anna Gavin; Harry Comber
Journal:  J Urban Health       Date:  2014-06       Impact factor: 3.671

7.  Prognostic Impact of Tumor Size on Pancreatic Neuroendocrine Tumor Recurrence May Have Racial Variance.

Authors:  Rui Zheng-Pywell; Amanda Fang; Ahmad AlKashash; Seifeldin Awad; Sushanth Reddy; Selwyn Vickers; Martin Heslin; Vikas Dudeja; Herbert Chen; John Bart Rose
Journal:  Pancreas       Date:  2021-03-01       Impact factor: 3.243

8.  Urban sprawl, obesity, and cancer mortality in the United States: cross-sectional analysis and methodological challenges.

Authors:  David Berrigan; Zaria Tatalovich; Linda W Pickle; Reid Ewing; Rachel Ballard-Barbash
Journal:  Int J Health Geogr       Date:  2014-01-06       Impact factor: 3.918

9.  Impact of individual and neighborhood factors on socioeconomic disparities in localized and advanced prostate cancer risk.

Authors:  Mindy C DeRouen; Clayton W Schupp; Juan Yang; Jocelyn Koo; Andrew Hertz; Salma Shariff-Marco; Myles Cockburn; David O Nelson; Sue A Ingles; Iona Cheng; Esther M John; Scarlett L Gomez
Journal:  Cancer Causes Control       Date:  2018-08-22       Impact factor: 2.532

10.  Social disparities, health risk behaviors, and cancer.

Authors:  Stefania Rametta; Giuseppe Grosso; Fabio Galvano; Antonio Mistretta; Stefano Marventano; Francesca Nolfo; Silvio Buscemi; Santi Gangi; Francesco Basile; Antonio Biondi
Journal:  BMC Surg       Date:  2013-10-08       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.